Overview

This book illustrates the significance of nanotechnology in the delivery of anticancer and antimicrobial drugs, biomimetic technologies, tissue engineering, sensing, diagnostics, and artificial enzymes. It first briefly discusses the use of nanotechnology for the delivery of anticancer medications, and the concept and applications of catalytically active nanomaterial-based artificial enzymes for sensing and diagnostic applications. It then explores the use of silver nanoparticle-based novel antimicrobials, and comprehensively reviews the role of nanomaterials in developing biomedical implants and tissue engineering applications. Lastly, it offers a detailed description of nanotherapeutics for combating human protozoan parasitic infections. Cutting across the disciplines, this book serves as a guide for researchers and scientists in biotechnology, medical science and material science.

Full Product Details

9789811599224

Table of Contents

Reviews

Author Information

Dr. Sanjay Singh is currently an Associate Professor at the Division of Biological and Life Sciences, Ahmedabad University, Gujarat, India. After completing his Ph.D. at CSIR-National Chemical Laboratory, Pune, India, he continued his research as a postdoctoral fellow at the University of Central Florida and the Pennsylvania State University, USA. His research interests include the synthesis of novel anti-cancer drug formulations and nanomaterials with biological, enzyme-like characteristics. He has received numerous national and international awards, such as an Endeavour Research Fellowship, YY Memorial Award (2016), International Association of Advanced Materials Scientists Medal (2017), Ambassador Australian Awards (2017), and an EMBO Fellowship. Dr Singh has published over 80 papers in international, peer-reviewed journals, and authored and co-authored several books and book chapters. He has also worked as a guest editor for various annual meetings of the Society for RedoxBiology and Medicine (SfRBM) and the World Molecular Imaging Society (WMIS). He is the Associate Editor-in-Chief of 3Biotech (Springer Nature), OncoTargets, and Therapy.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available